CIK: 1695076 - Address: 501 Second Street, Suite 200, San Francisco, CA 94107
5 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

8/3/23 20:13
8/1/23
INZYInozyme Pharma, Inc.DEHealthDrugPharmaceutical PreparationsPivotal Bioventure Partners Fund I, L.P.CADP4,0004.8008331131,572I
4/20/22 18:22
4/19/22
INZYInozyme Pharma, Inc.DEHealthDrugPharmaceutical PreparationsPivotal Bioventure Partners Fund I, L.P.CADP3,9483.6901,070672,661I
7/28/20 18:15
7/28/20
INZYInozyme Pharma, Inc.DEHealthDrugPharmaceutical PreparationsPivotal Bioventure Partners Fund I, L.P.CATP.d3,00016.000188131,591I
7/1/20 16:14
6/30/20
AKUSAkouos, Inc.DEHealthDrugPharmaceutical PreparationsPivotal Bioventure Partners Fund I, L.P.CATP.d5,00017.000294201,794I
10/2/18 21:39
9/28/18
ETTXEntasis Therapeutics Holdings Inc.HealthDrugPharmaceutical PreparationsPivotal Bioventure Partners Fund I, L.P.CATP.d5,06615.000338401,180I

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact